|
|
|
Volumn 24, Issue 3 SUPPL. 8, 1997, Pages
|
|
Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GEMCITABINE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
CISPLATIN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
RIBONUCLEOTIDE REDUCTASE;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG TOLERANCE;
HUMAN;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
NAUSEA;
PATIENT COMPLIANCE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SURVIVAL RATE;
THROMBOCYTOPENIA;
VOMITING;
WORLD HEALTH ORGANIZATION;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
COMPARATIVE STUDY;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
FEMALE;
LEUKOPENIA;
LUNG TUMOR;
MALE;
METASTASIS;
MIDDLE AGED;
NEUTROPENIA;
TREATMENT OUTCOME;
ADULT;
AGED;
ALOPECIA;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LEUKOPENIA;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NAUSEA;
NEOPLASM METASTASIS;
NEUTROPENIA;
RIBONUCLEOTIDE REDUCTASES;
SURVIVAL RATE;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
VOMITING;
|
|
EID: 0030959034
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (30)
|
